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The first major finding that allowed us
to progress in our understanding of
autoimmune blistering skin diseases
was that chronic blistering diseases of
the skin could be differentiated. The
initial major clinical differentiation was
between pemphigus and pemphigoid
and, still today, our major progress in
understanding these diseases comes
from patients with pemphigus and
pemphigoid. Therefore, in this review
of historical perspectives, we will focus
on pemphigus and pemphigoid. The
early history and the clinical and
histological differentiation of pemphi-
gus, pemphigoid, and related diseases
is beautifully described in a classic
monograph by a giant in the field,
Walter Lever (1965). Although many
contributed to the differentiation at the
histological and clinical level, Walter
Lever, informed by his own patients
and their histology, was a major figure
in synthesizing and distilling the es-
sence of this information.
PEMPHIGUS
According to Lever (1965), MacBride
may have carefully described the first
cases of pemphigus vulgaris in 1777.
Cazenave is credited with identifying
the pemphigus foliaceus subtype in
1844 (Lever, 1965). What really al-
lowed unambiguous differentiation of
the autoimmune bullous diseases was
the characterization of their histology.
In his classic work in 1943, Civatte
discovered acantholysis (loss of cell-cell
adhesion) in pemphigus and differen-
tiated this histology from the subepi-
dermal blisters of what was probably
bullous pemphigoid and/or dermatitis
herpetiformis (1943). Another approxi-
mately 20 years went by before the
seminal discovery of Beutner and Jor-
don (then a medical student) that the
sera of patients with pemphigus vulgaris
have IgG autoantibodies against the cell
surface of keratinocytes as determined
by indirect immunofluourescence
(1964). The discovery of these auto-
antibodies led to the important under-
standing that pemphigus is an IgG-
mediated autoimmune disease (Fig-
ure 1). That the autoantibodies actually
cause the blister of pemphigus was
shown in human skin organ culture by
Schiltz and Michel (1976) and by
passive transfer to neonatal mice by
Anhalt, Diaz and co-workers (Anhalt
et al., 1982). Finally, pemphigus anti-
gens were discovered to be desmoso-
mal cadherins. By immunochemical
methods pemphigus foliaceus antigen
was shown to be a desmosomal glyco-
protein, now called desmoglein 1 (Kou-
lu et al., 1984), and by cDNA cloning
pemphigus vulgaris autoantibodies de-
fined a new desmosomal cadherin,
desmoglein 3 (Amagai et al., 1991).
These studies demonstrated that the
autoantibodies in pemphigus are direc-
ted against molecules in cell adhesion
structures, a conclusion particularly
gratifying in diseases whose pathology
is caused by loss of cell adhesion. Such
discoveries also have allowed new
diagnostic methods for these diseases
(Ishii et al., 1997) and will ultimately
lead to more targeted therapy.
BULLOUS PEMPHIGOID
Although Civatte and others had noted
that some bullous diseases were sub-
epidermal and therefore distinct from
pemphigus, Lever, in analyzing pre-
vious data and studying his own
patients, clearly defined bullous pem-
phigoid as a distinct disease (1953)
from pemphigus and also from derma-
titis herpetiformis as defined by Duhr-
ing (Figure 2). In pemphigoid patients,
IgG directed against epidermal base-
ment membrane was found in serum by
indirect immunofluorescence, and in
skin by direct immunofluorescence
(Beutner et al., 1965). This discovery,
by Beutner, Lever, Jordon, and others,
provided an immunologic basis for
differentiating pemphigoid from pem-
phigus. Skin organ culture and passive
transfer models did not work well in
pemphigoid. More complicated in vitro
models indicated that not only IgG but
complement and inflammatory cells
were necessary for blister formation in
pemphigoid (Gammon et al., 1980).
Surprisingly, two different bullous pem-
phigoid antigens were identified and
cloned, called BP230 (Stanley et al.,
1981, 1988) and BP180 (Labib et al.,
1986; Diaz et al., 1990), according to
their molecular weight in kilodaltons.
Mouse models of disease indicated that
the BP180 is the pathogenic antigen
and that IgG, complement, and inflam-
matory cells are necessary for disease
(Liu et al., 1993). Both of these antigens
are part of the hemidesmosome, an
adhesion structure that anchors the
basal keratinocyte to the basement
membrane, a logical and satisfying
finding in a disease in which that
adhesion is lost.
As in pemphigus, these discoveries
have allowed new diagnostic tests
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(Giudice et al., 1994) and insight into
new targets to treat disease.
OTHER AUTOIMMUNE BLISTERING SKIN
DISEASES
Characterization of the pathology and
pathophysiology of pemphigus and
bullous pemphigoid led to our being
able to categorize other related auto-
immune blistering diseases that are
distinct. Dermatitis herpetiformis, ori-
ginally described by Duhring (1983),
was not histologically differentiated
from pemphigoid for many years (Pier-
ard and Whimster, 1961), and was
finally absolutely differentiated by its
immunological finding of granular im-
munoglobulin deposition, specifically
IgA, in the papillary dermal tips (Cor-
mane, 1967; van der Meer, 1969).
Subsequently linear IgA at the base-
ment membrane zone was discovered
(Chorzelski et al., 1971) in some
patients who now are felt to have linear
IgA disease, which can mimic derma-
titis herpetiformis. Benign mucosal
pemphigoid (a term coined by Lever
(1953)), also called cicatricial pemphi-
goid, first reported (according to Lever
(1965)) by Wichmann in 1794 (Wich-
mann, 1794), was differentiated from
bullous pemphigoid mainly by its
clinical course of erosive lesions in
mucous membranes with scarring (Le-
ver, 1953) in spite of similar histology
and immunofluorescence findings
(Bean et al., 1972). Epidermolysis
bullosa acquisita was originally defined
by its mechanobullous nature that
resembled inherited epidermolysis bul-
losa (Roenigk et al., 1971); however,
when it was discovered that the IgG
seen at the epidermal basement mem-
brane (Kushniruk, 2007) could be
localized to the base of 1 molar sodium
chloride split skin, it became apparent
that some patients previously diag-
nosed with bullous pemphigoid actu-
ally had epidermolysis bullosa
acquisita of an inflammatory type
(Gammon et al., 1984). The antigen in
epidermolysis bullosa was found to be
type VII collagen (Woodley et al.,
1986).
CONCLUSION
These diseases have provided remark-
able insight into the cell biology of
adhesion in stratified squamous epithe-
lia. The first hemidesmosomal mole-
cules as well as new desmosomal
molecules were discovered because of
the antibodies from these patients.
These antibodies also provided direct
evidence of the function of these
molecules. Finally, and most impor-
tantly, probing the pathophysiology of
these diseases has allowed improved
diagnosis and therapy of these severe
and disfiguring conditions.
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Figure 1. Pemphigus historical timeline. IF, immunofluorescence.
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Figure 2. Bullous pemphigoid historical timeline. IF, immunofluorescence.
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